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Spermatogenesis is a complicated process in which sperm is susceptible to various chemotherapy drugs such as
cyclophosphamide (CP). As olive leaf extract (OLE) and its active ingredient, oleuropein, have variousantioxidant,
anti-apoptotic, and anti-inflammatory properties the aim of the present study was to investigate the effects of OLE
and oleuropein on male reproductive function focusing antioxidative effects and histological modifications in the
testes of CP-exposed mice.
In order to do this, 80 NMRI male mice were divided into eight groups including control group, group received
CP, group received OLE, group received oleuropein, group received OLE following CP exposure, group received
oleuropein following CP exposure, group received OLE plus oleuropein and group received OLE plus oleuropein
following CP exposure. In all groups CP (single dose of 100 mg/kg (, OLE (100 mg/kg for consequence 28 days)
and oleuropein (100 mg/kg for consequence 28 days) were injected intraperitoneally. Moreover, testis histology,
sperm parameters and serum levels of LH, FSH, MDA and antioxidant capacity were investigated. Results showed
that CP caused oxidative state and abnormal changes in sperms and testes. Besides, treatments with oleuropein
and OLE led to mitigate the harmful effects of CP on the male reproductive system. In conclusion, our findings
showed that olive's compounds can diminish the hazardous effects of CP on spermatogenesis in mice.1. Introduction
Cyclophosphamide (CP) is an anticancer drug that is converted into
an active alkylating metabolite in the body [1]. CP converted to phos-
phoramide mustard and acrolin. Phosphoramide mustard is responsible
for the anticancer properties of CP, but acrolein interferes with the
antioxidant defense system and produces large amounts of oxidants [2].
Oxygen-free radicals are responsible for the toxic effects of CP such as cell
death, apoptosis, necrosis and formation of various tumors [1, 2].
Olive is an evergreen tree belonging to the oleracea family. Among
different parts of the olive tree, fresh leaves have the highest antioxidant
activity [3, 4]. Oleuropein, as the most abundant compound in olive leaf
extract (OLE), has antioxidant activity [4]. It has been shown that
Oleuropein exerted antihypertensive, anti-inflammatory, hypoglycemic,
and antiarrhythmic effects [4, 5, 6, 7]. Oleuropein in OLE increases
GnRH and testosterone secretion [8, 9]. In addition, the acidicimi.m@skums.ac.ir (M. Rahimi-m
orm 22 January 2020; Accepted
vier Ltd. This is an open access acompounds in OLE inhibit the activity of the aromatase enzyme which
consequently increases androgens (testosterone and dihydrotestoster-
one) in the body [10, 11].
The use of chemotherapy drugs has significant negative effects on the
reproductive system especially gonads [12]. Usage of medicinal plants to
mitigate these harmful effects and treat certain conditions such as hor-
monal imbalances, oligospermia, low sperm motility, and prostate
inflammation has long been considered [13].
Due to the susceptibility of the spermatogenesis process, the admin-
istration of CP may decrease sperm count [14]. Besides, Cyclophospha-
mide led to damaging to spermatogenesis-related stem cells and the
destruction of spermatogonial cells [6, 15].
Considering various pharmacological effects of olive and oleuropein
and hazardous effects of CP on spermatogenesis, this study aimed to
evaluate the protective effects of these compounds on male reproductive
function in mice exposed to CP focusing on its antioxidant properties.adiseh).
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2.1. Plant preparation and extraction
Fresh leaves were gathered from Shaft village, Gilan province, North
of Iran on April 2018. Moreover, after identifying the herb by an expert
botanist (Shahrokhi, A, M.S., Research Center of Agriculture and Natural
Resources, P.O. Box 415, Shahrekord, Iran); it was deposited to the
Herbarium Unit of Shahrekord University of Medical Sciences (Herbari-
um No. 1020). They were dried in the shade away from sunlight at 25 C
in laboratory. To extract the dried and pulverized sample, ethanol 70%
was used by maceration method. In the next step, After 72 h, using
Whatman filter paper and Buchner funnel, the liquid was filtered and the
obtained extract was concentrated in a rotary vacuum evaporator at 38
C. Furthermore, the concentrated extract was incubated at 37 C for
final drying. The oleuropein compound was also purchased from Sigma
(Lot No. 12247, St. Louis, MO, USA).2.2. Animals and grouping
In this experimental study, 80 adult NMRI mice weighing approxi-
mately 30 g and aged 8–12 weeks were divided into eight groups:
group 1 (control): received no treatment or injection, group 2:
received a single dose of CP, group 3: received OLE, group 4: received
oleuropein, group 5: received OLE after CP exposure, group 6: received
oleuropein after CP exposure, group 7: received OLE þ oleuropein; and
group 8: received OLE þ oleuropein after CP exposure.
CP was injected intraperitoneally at a single dose of 100 mg/kg. OLE
(100 mg/kg) and oleuropein (100 mg/kg) were also administered
intraperitoneally in the respective groups for 28 constant days [16].
Doses of agents were chosen based on previously published studies as
well as our pilot study [17, 18, 19]. All stages of experimentation were
performed in accordance with the regulations of the University and the
Guide for the Care and Use of Laboratory Animals of the National In-
stitutes of Health (Ethics code: IR. SKUMS.REC.1397.30).2.3. Measurement of serum parameters
At the end of the study, the animals were anesthetized and blood
samples were collected in microtubes and then centrifuged. Standard
ELISA kits were used to measure FSH and LH levels [20, 21]. Setiawan's
procedure was used to measure serum malondialdehyde (MDA) levelsFigure 1. Assessment of sperm morphology using aniline blue staining: A) Healthy
with curved midpiece abnormalities that remove the head from the tail axis and hav
dead and not able to fertilize the egg; D) Sperm with curved tail, cytoplasmic dropl
2
[22]. Serum antioxidant capacity was evaluated by the ferric
ion-reducing system (FRAP) [23].
2.4. Investigation of sperm parameters
Sperm parameters including sperm count, motility, viability and
morphology were investigated according to the procedures used in a
previous study. Epididymes were kept in the Ham's F10 medium. Then
slicing with a scissor in an incubated at 37 C for 5 min in order to release
of sperms, using eosin-necrosis (E&N) staining, the percentage of live
sperms was determined under a microscope. To investigate the sperm
morphology, a drop of 20 μl of sperm suspension was spread on a slide
and after drying, Aniline-blue staining was performed to determine
spermmorphology under a light microscope at a magnification of 400. 10
slides were examined from each animal and parameters including head
abnormalities, midpiece defects, and faulty tail were assessed. To assess
sperm motility, a small drop of the sample was placed on the slide, and
then examined at a magnification of 400 under the microscope. The
percentage of motile spermatozoa in several microscope fields was esti-
mated and reported as an average of percentage. In order to evaluate the
sperm count, sperm suspension was diluted in 3% normal saline in a
proportion of 1–9, and then a drop of the above solution using a micro-
pipette was gently transferred to the neobar slide. After 5 min using a
magnification of 40 spermatozoa with head, middle and tail pieces were
counted [20, 21, 24].
Sperm motility was evaluated according to the following 3 grades: a)
grade 1 (immotile): sperms which have no motility; b) grade two (in situ
or non-progressive): Sperm whose tails move but have no forward mo-
tion; (c) grade Three: Sperm that swim rapidly in a straight forward di-
rection [24]. To evaluate sperm morphology, three abnormal sperms
including head abnormalities, midpiece defects, and faulty tail were
divided into two groups (Figure 1) [25].
2.5. Histological evaluation
In all groups, the right testes were histologically studied by
hematoxylin-eosin (H & E) staining. To evaluate the quantitative pa-
rameters of seminiferous tubules, linear gradients on the microscope lens
were used. To do this, twenty seminiferous tubules in round or nearly
round cross-sections were randomly selected from each sample. Twenty
cells per each animal were studied. Based on the morphology of each cell,
spermatogonia, primary spermatocytes, round spermatids and sperma-
tozoa were counted in the cross-sections of 20 seminiferous tubules persperm with perfectly transparent head and extended and regular tail; B) Sperm
e low sperm motility; C) Sperm with amorphous (headless) abnormality that is
et tail and short tail that disrupt sperm motility and decrease cell viability.
A. Rostamzadeh et al. Heliyon 6 (2020) e03785animal. Only round tubules were counted, and tubes that had an inclined
section or were elliptical or contained cells that had fallen into the lumen
were not counted. Tubules that were elliptical or had inclined sections
were not examined for studying seminiferous tubules. At 400 magni-
fication, the diameters of the seminiferous tubules were examined so that
the distance between the basement membrane on one side of the tubule
and the basement membrane of the other side was measured.
Two diameters perpendicular to each other were measured, and then
the mean length of the diameters in each tubule was calculated. Simi-
larly, the mean diameter inside the seminiferous tubule and the thickness
of the germinal epithelium were measured in micrometer [26].2.6. Statistical analysis
The data were entered into SPSS version 20 and analyzed using one-
way ANOVA and Tukey's post-test. The significance level was considered
at level of P < 0.05.
3. Results
3.1. Results of serum parameters
The results showed that serum FSH level were not significantly
different between the CP group and the control group. However, serum
FSH levels were significantly higher in healthy mice received the OLE
plus oleuropein than in the control group (P < 0.001) (Table 1). Serum
LH levels significantly decreased in the CP- received group in comparison
with the control group (P < 0.001). Furthermore, a significant difference
in LH level was also observed between CP- received group which treated
with OLEþ oleuropein (P< 0.05). Serum antioxidant capacity in the CP-
received group was significantly lower than control group (P < 0.001).
SerumMDA levels were significantly higher in the CP-treated group than
in the control group (P < 0.001). Besides, MDA levels were significantly
lower in groups received oleuropein and/or OLE in compared with theTable 1. Quantitative comparison (mean  SD) of FSH, LH, antioxidant capacity an





1- Control 297.6  1.68 21
2- CP 183.4  1.61*** 35
3- OLE 312.7  2.11 2.9
4- oleuropein 298.2  1. 49 21
5- CP þ OLE 197.6  2.36 31
6- CP þ oleuropein 191.5  1.11 32
7- OLE þ oleuropein 321.6  1.54 18
8- CP þ OLE þ oleuropein 214.4  2.52 29
Table 2. Quantitative comparison (mean  SD) of sperm count and motility. Sample






1- Control 75.5  2.21 4
2- CP 45.5  1.25*** 9
3- OLE 84.2  1.6* 4
4- oleuropein 79.5  1.9 4
5- CP þ OLE 56  1.94 7
6- CP þ oleuropein 49.7  1.51 8
7- OLE þ oleuropein 86.5  1.8** 3
8- CP þ OLE þ oleuropein 59.2  1.34##,** 7
3
CP-received group (P < 0.001 and P < 0.05, respectively). In addition,
simultaneous administration of the OLE and oleuropein decreased MDA
levels in comparison with CP-received group (P < 0.01) (Table 1).3.2. Sperm parameters
The results showed that CP exposure reduced sperm count in com-
parison with the control group (P < 0.001). OLE treatment in healthy
mice had a significant effect on the increase in sperm count in compar-
ison with the control group (P < 0.05). In addition, simultaneous treat-
ment with OLE and oleuropein significantly increased sperm count in
comparison with the control group (P< 0.01). Besides that, simultaneous
treatment of the OLE plus oleuropein in CP-treated mice significantly
increased sperm count in comparison with group received CP (P < 0.01)
as well as in compared to the control group (P < 0.01).
Motility: Grade 1 (immotile): The results showed that CP exposure
significantly increased the percentage of immotile sperm in comparison
with control group (P < 0.001). Grade 2 (in situ): CP- received group
showed a significant increase in the count of sperm with in situ motility
in comparison with the control group (P < 0.01). In group received OLE
plus oleuropein situ sperm motility significantly reduced in comparison
with CP-received group (P < 0.01). Grade 3 (progressive): The results
showed that CP exposure, in comparison with the control group, signif-
icantly reduced the percentage of progressive motility (P < 0.05). The
results showed a significant increase in progressive sperm count in group
received OLE plus oleuropein in compared with the CP-received group (P
< 0.05) (Table 2).
Viability: We showed that CP exposure group significantly reduced
the percentage of viable sperm in comparison with the control group) (P
< 0.0001) (Table 3).
Results showed that simultaneous administration of the OLE with
oleuropein significantly increased the count of viable sperm in compar-
ison with the CP- received group (P< 0.01) as well as in compared to the
control group (P < 0.01).d MDA levels. Samples were taken from 10 animals in each group. Data were
< 0.001compared with control group and #P < 0.05 and ##P < 0.01 compared
A FSH LH
2.1  2.96 4.68  0.31 4.26  0.1
4.6  3.47*** 3.11  0.2 2.45  0.16***
 2.83 6.31  0.52 4.31  0.08
0.7  3.09 6.31  0.57 4.28  0.11
9.4  .07## 3.73  0.25 3.11  0.21
9.8  2.67# 3.21  0.21 2.81  0.23
9.3  4.24 7.56  0.37*** 4.6  0.24
8.1  2.62## 4.48  0.24 3.36  0.16#
s were taken from 10 animals in each group. Data were analyzed using one0way
d with control group and #P < 0.05 and ##P < 0.01 compared with CP-received
perm motility
mmotile In situ Progressive
.8  0.8 4.8  0.8 42.2  1.74
.4  0.56*** 10.9  0.52** 32.5  1.35*
 0.25 4.4  0.47 46  1.43
.5  0.52 4.8  0.46 44.7  1.17
.7  0.59 8.7  0.44 36.7  1.01
.8  0.38 9.6  0.26 34.7  1.23
.6  0.4 3.6  0.6 50.5  2.57
.2  0.71 7.6  0.4## 39.8  1.2#
Table 3. Quantitative comparison (mean  SD) of viability and morphology of sperm. Samples were taken from 10 animals in each group. Data was analyzed using
one0way ANOVA followed by tukey's post test. ***P < 0.001compared with control group and ##P < 0.01 and ###P < 0.001 compared with CP-received group.
Parameter
Groups
Viable sperm Sperm morphology
Head abnormalities Midpiece defects Faulty tail
1-Control 61  1.09 1.1  0.23 2.5  0.45 2  0.36
2- CP 36.2  1.44*** 5.5  0.42*** 6.2  0.64*** 7.4  0.63***
3- OLE 63.7  3.14 0.8  0.2## 1.7  0.36 1.6  0.3
4- oleuropein 62.1  1.2 0.9  0.17 2.1  0.27 1.8  0.35
5- CP þ OLE 40.7  1.53 3.7  0.49 4.9  0.45 5.2  0.51
6- CP þ oleuropein 38.4  0.73 4.7  0.33 5.7  0.47 6.7  0.9
7- OLE þ oleuropein 64.5  1.24 0.4  0.16 1.2  0.29 1.1  0.27
8- CP þ OLE þ oleuropein 48.5  1.33##, ** 3  0.25### 3.8  0.48## 4.4  0.54
A. Rostamzadeh et al. Heliyon 6 (2020) e03785Morphology: Head Abnormalities: The results showed that CP expo-
sure significantly increased sperm with abnormal head morphology in
comparison with the control group (P < 0.001). Administration of the
OLE significantly decreased sperm with abnormal head in comparison
with the CP-received group (P < 0.01). Simultaneous administration of
the OLE with oleuropein significantly decreased sperms with abnormal
head in comparison with Cp-received counterpart (P < 0.001). Midpiece
defects: The results showed a significant increase in midpiece defects in
CP-received group in comparison with the control group (P < 0.0001).
Furthermore, co-administration of OLE with oleuropein significantly
decreased sperm with midpiece abnormalities in comparison with CP-
received counterpart (P < 0.01) (Table 3). Faulty tail sperm: The re-
sults showed that the percentage of sperm with faulty tail significantly
increased following CP administration in comparison with the control
group (P < 0.001).3.3. Qualitative histological results
The results of histopathologic examination of the testis in different
groups show different and varying degrees of degenerative changes in the
testicular tissue (Figure 2). Following CP administration, the diameter of
the seminiferous tubules decreased, the seminiferous tubules were
irregular and the basement membrane was crimped, the epithelium also
had severe atrophy and vacuolization as well as spermatogenesis was not4
seen at all stages. In CP- received group, primary spermatocytes at
pachytene stage and arrest were immotile. There was substantial edema
and inflammation along with a decrease in the number of seminiferous
tubules (Figure 2 E). Our findings showed that administration of OLE,
oleuropein and their combination therapy partially mitigated the nega-
tive effects of CP on testicular tissue.
4. Discussion
Spermatogenesis is a long and complex process, during which the
sperm is sensitive to various internal and external stressors [27]. The
most common cause of infertility in men is their inability to produce
adequate number of healthy and active sperms [28, 29]. The admin-
istration of chemotherapy drugs lead to harmful effects on the gonads
and its damage to spermatogonia-producing germ cells which conse-
quently caused infertility [12]. Cyclophosphamide (CP) is an anti-
cancer drug that is converted into an active alkylating metabolite in the
body leading to hazardous effects on male gonads [30]. Meistrich et al.
(2013) showed that CP at therapeutic doses decreased sperm count in
patients [31]. Moreover, a study by Elangovan et al. (2006) on the
reproductive system of mice exposed to CP showed that this drug
reduced the blood LH and FSH levels [32]. The present study showed
that CP decreased the sperm parameters as well as decreased levels of
sex hormones.Figure 2. The testicular histopathological in-
vestigations in experimental groups showing different
degrees of degenerative changes in testicular tissue:
A) Group 1 (control); B) Group 3 (treated with OLE
alone); C) Group 4 (treated with oleuropein alone); D)
Group 7 (simultaneously treated with OLE and
oleuropein without cyclophosphamide administra-
tion); E) group 2 (treated with cyclophosphamide
alone); F) Group 5 (treated with OLE and cyclophos-
phamide); G) group 6 (treated with oleuropein and
cyclophosphamide); H) Group 8 (simultaneously
treated with OLE and oleuropein with cyclophospha-
mide administration). Please note that all figures are
presents as supplementary file.
A. Rostamzadeh et al. Heliyon 6 (2020) e03785Flavonoids are natural polyphenolic compounds in OLE that exerted
anti-inflammatory effects by reducing the production of nitric oxide and
prostaglandins [33]. Oleuropein has high antioxidant power which can be
found in olive oil and is able to exert anti-inflammatory and antioxidant
effects [34]. Previous studies have been determined that OLE significantly
increased spermatogenesis and sperm quality [35]. A study by Sarbishegi
et al. (2017) showed that oleuropein increasedspermparameters. Increased
total antioxidant capacity (TAC) as well as decreased malondialdehyde
(MDA) level in the testes in animals received rotenone (ROT)were reported
[36]. The findings of our study showed that injection of OLE in mice
exposed to CP relatively had greater antioxidant, protective, and even
regenerative effects than oleuropein. In addition, simultaneous injection of
OLE in combined with oleuropein increases LH levels and decreases MDA
levels in CP-treated rats as well as improves the histological characteristics
of seminiferous tubules. Based on our findings, future studies warranted
might also find more mechanisms of action of these compounds.
It has been determined that oxidative states like increase in the MDA
level and/or decrease in antioxidant capacity negatively affected sper-
matogenesis [37, 38]. Furthermore, high levels of oxidants result in the
destruction of bases, cross-linking of proteins, and DNA breakdown and
consequently activates apoptotic cascade reactions [39, 40, 41]. Our
findings also showed that administration of CP increased the MDA level
as well as decreased the antioxidant capacity. We found that
co-administration of OLE þ oleuropein significantly mitigated these
negative effects. It has been determined that aromadendrine, a compo-
nent of the flavonoid pattern of Olea europaea L. possessed
anti-inflammatory activity [42]. Further studies must be conducted in the
future to find the exact mechanisms of action of the oleuropein and OLE
and its active components like aromadendrine in this field.
5. Conclusion
The results of the present study showed that cyclophosphamide
caused significant alterations in the testes tissue, negatively affected the
sperms' parameters (number, mobility and morphology) as well as
changed the level of sex hormones. We found that administration of OLE
and oleuropein exerted protective effects against CP- induced negative
alterations in the male reproductive system in mice.
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